Woolfson Eye Institute is pleased to announce the appointment of Dr. Doyle Stulting as Director of Corneal Disease & Research. With the addition of Dr. Stulting, Woolfson Eye Institute will take patient care to the next level, further enhancing the strength and expertise of our physician team. Dr. Stulting is a pioneer in corneal disease research and LASIK. His basic research efforts have opened the doors to deeper understanding of the mechanisms of corneal transplant rejection and herpetic ocular disease and to new treatment paradigms. One of the most frequently cited investigators in his field, Dr. Stulting is the author of more than 200 publications and countless other articles based on his extensive clinical research in corneal transplantation, laser treatment of refractive errors, the management of dry eye, and cataract surgery. A sought-after speaker on both refractive surgery and cornea topics, he is also a revered authority for patients with complex problems that generate difficult questions about refractive surgery outcomes.

In a career that has spanned more than 30 years, Dr. Stulting has been conducting basic and clinical research in corneal disease, corneal transplantation and refractive surgery. He participated in the first physician-sponsored clinical investigation of LASIK, prior to the refractive laser’s FDA approval in the United States. Dr. Stulting is an experienced surgeon and medical monitor for a clinical trial using a new intraocular telescope for patients with cataract and severe central vision loss from macular degeneration. He is also a leader in the investigation of new laser technologies for the treatment of damaged corneas and Principle Investigator for a clinical trial of a new technology that is likely to revolutionize the management of keratoconus—a disease that today accounts for 20% of the corneal transplants performed in the USA. He has also organized a key multi-center clinical trial to evaluate the effect of tissue typing on corneal transplantation.

Stulting retired from Emory after a 29-year career as Hughes Professor of Ophthalmology and Director, Section of Cornea, External Disease, and Refractive Surgery. He was also Medical Director of Emory Vision, Emory University’s refractive surgery center. Dr. Stulting has trained more than 60 fellows in his sub-specialty and countless residents, many of whom have gone on to distinguish themselves in the profession. Additionally, he serves as Editor-In-Chief of the journal Cornea, President-Elect of the American Society of Cataract and Refractive Surgery, a member of the Board of Directors of the Eye Bank Association of America, and a member of the Board of Directors of the Georgia Eye Bank. He also served as a member of the Ophthalmic Devices Panel, an advisory group for the FDA, for 10 years and chaired that panel for three years. Dr. Stulting received the FDA’s citation for Excellence, Commitment and Outstanding Service in Protecting the Public Health in 1988, the prestigious Paton Award from the Eyebank Association of America in 2005, and the American Academy of Ophthalmology’s Lifetime Achievement Award in 2010. He also delivered the Leopold Lecture at Wills Eye Hospital in Philadelphia and the Paton Lecture at Baylor University in Houston.

Dr. Stulting graduated from Duke University with BS, MD, and PhD degrees, was an intern and resident in internal medicine at Washington University, a resident in ophthalmology at Bascom Palmer Eye Institute, and a Fellow in Cornea and External Disease at Emory University.

As a licensed private pilot (for 36 years), he enjoys flying his Bonanza A-36. He also enjoys dancing, hiking, mountain biking, and loves the out-of-doors.